Home OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...
 

Keywords :   


OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...

2013-12-12 06:00:00| Industrial Newsroom - All News for Today

House Committee on Oversight & Government Reform, Subcommittee on Energy Policy, Health Care & Entitlements held a hearing entitled, "FDA Check-Up: Drug Development and Manufacturing Challenges." Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals and Chairman of BIO’s Emerging Companies Section Governing Board, presented testimony emphasizing the positive indicators that demonstrate the biopharma industry is rebounding, but significant financial and regulatory challenges ...This story is related to the following:Green & CleanSearch for suppliers of:

Tags: on drug behalf bio

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
24.115 2 PG
24.11215103TW 17svtw
24.11 Switch light
24.11Dr.SLUMP 19
24.11layover LP
24.11PING i230 6W 5
24.11BTS CD
24.11HG 56
More »